Life Science Tools and Reagents: Global Markets


April 1, 2011
173 Pages - SKU: WA6314971
License type:
Countries covered: Global

The life science tools market has shown steady growth over the last couple of years despite the economic downturn. This market is currently valued at more than $42 billion and is projected to increase at compound annual growth rate (CAGR) of 13.6% to reach approximately $81 billion in 2016. Reagents and tools for DNA and RNA research are currently worth $27 billion and expected to increase at a 12.2% compound annual growth rate (CAGR) to reach $48 billion in 2016. Cell biology reagents represent at least 30% of the life science research tools market. This particular segment is currently estimated at $10 billion and predicted to at least double its value in the next 5 years to reach $24 billion, a 19.1% compound annual growth rate (CAGR).


Additional Information

INTRODUCTION

STUDY GOALS AND OBJECTIVES

This BCC Research report, Life Science Tools and Reagents: Global Markets, provides an overview of the current overall state of the life science tools and reagents industry, existing products on the market, and a detailed analysis of the competitive environments, including new potential markets for novel products and assay development. This study includes information about significant players, trends, and obstacles and other information affecting the market for research tools and reagents in the life science sector.

REASONS FOR DOING THIS STUDY

Reagents and research tools used in the life sciences are essential parts of routine laboratory research. The discovery of the PCR (polymerase chain reaction) is one of the best examples where a technical method opened a new era of molecular biology, and its significance was acknowledged with a Nobel Prize in 1993.

Yet, despite such contributions and its importance in biomedical research, potential investors often overlook the life science tools industry. It is important to understand that this market follows different business models as compared to the pharmaceutical industry. While pharmaceuticals need more financial leverage and time to develop successful drugs, reagent development is less risky. Reagents companies develop various strategies to grow and expand their activities, offering new outlooks on biotechnology and pharmaceutical market development. In addition, scientific trends, government policies, and the economy in general affect this industrial market differently as compared to pharmaceutical and drug discovery ventures. For example, the launch of new reagents or products is not affected by strict FDA guidelines.

This report highlights the main segments of the life science tools and reagents industry and its major market participants, including current and future market trends. Drivers and challenges in each segment of this industry will be discussed in detail, including forecasts for the next 5 years.

SCOPE OF REPORT

This report is essentially a business tool that can help market players evaluate new commercial opportunities in the life science tools and reagents market. The geographic scope of this study is global. This market is complex and consists of many different segments, each of which is affected differently by scientific and technological developments. This report identifies the main positive and negative factors affecting each segment, and forecasts market growth, future trends, and product and assay development in every major segment of this market.

METHODOLOGY AND INFORMATION SOURCES

Both primary and secondary research methodologies were used in preparing this study. Initially, a comprehensive and exhaustive search of the literature on drug discovery and already marketed products was conducted. These secondary sources included drug discovery and science-related journals, textbooks, press releases, marketing literature, other product/promotional literature, annual reports, security analyst reports, and other publications. A patent search and analysis were also conducted.9
In a second phase, a series of semi-structured interviews was conducted with company representatives, bench scientists, marketing representatives, and other personnel at biotechnology and pharmaceutical companies. Other sources included academics, technology, and consulting companies. Subsequent analysis of the documents and interviews notes was iterative.

ANALYST CREDENTIALS
Dr. Marianna Tcherpakov has more than 7 years experience as a bench scientist specializing in biochemistry, cell biology, and industrial assay development. She has contributed to a number of scientific publications and holds several patents. She has expertise as an assay development scientist and is familiar with different research field trends and likely future developments.

More Molecular Biology reports by BCC Research

Polymerase Chain Reaction (PCR) Technologies by BCC Research
REPORT HIGHLIGHTSThe global PCR products market is expected to grow from nearly $5 billion in 2010 to nearly $8 billion by 2015, at an estimated ...
See all reports like this >>

More Global Molecular Biology reports

Global Quantitative and dPCR Instrumentation and Consumables Purchasing Trends by Frost & Sullivan
The primary objective of this research is to identify trends for quantitative polymerase chain reaction (PCR) techniques, specifically the use of nascent digital PCR (dPCR) ...
Pipettes And Pipettors by Global Industry Analysts
This report analyzes the worldwide markets for Pipettes and Pipettors in Million Units and US$ Million by the following Product Segments: Electronic Pipettors, Mechanical Pipettors, ...
Laboratory Chemical Reagents by Global Industry Analysts
This report analyzes the worldwide markets for Laboratory Chemical Reagents in US$ Million by the following Product Segments: Molecular Biology (Monoclonal & Polyclonal Antibodies, Gene ...
Polymerase Chain Reaction (PCR) - Products/Tools - A Global Market Watch, 2009-2015 by Axis Research Mind
The global PCR market is projected to reach around US$27.4 billion by 2015, with a Compounded Annual Growth Rate (CAGR) of 13.9% for the analysis ...
See all reports like this >>